Module 1 — Regional administrative
Scope: Region-specific forms, labeling, patent/certification (US), application forms (EU)
Examples: FDA forms, SPL labeling, environmental assessment, REMS (US); application form, SmPC, artwork (EU)
Regulatory Reference
Common Technical Document (CTD) modules 1–5 as used in electronic submissions (eCTD) to FDA and EMA — folder logic, regional differences, and validation expectations.
The CTD is the ICH-organized content structure for marketing applications. The eCTD is the electronic implementation: XML backbone, leaf attributes, lifecycle operations (new, replace, delete), and regional validation rules.
NDAs, BLAs, ANDAs, and major supplements are filed in eCTD format for FDA. EMA centralized procedures use eCTD via the Common European Submission Platform (CESP).
Scope: Region-specific forms, labeling, patent/certification (US), application forms (EU)
Examples: FDA forms, SPL labeling, environmental assessment, REMS (US); application form, SmPC, artwork (EU)
Scope: Overviews and summaries across quality, nonclinical, and clinical
Examples: 2.2 QOS, 2.3–2.7 quality/nonclinical/clinical overviews and written summaries
Scope: Drug substance, drug product, facilities, appendices
Examples: 3.2.S API, 3.2.P drug product, 3.2.A appendices, 3.2.R regional info
Scope: Pharmacology, PK, toxicology study reports and literature
Examples: 4.2.1 primary pharmacodynamics, 4.2.3 toxicology, 4.3 literature references
Scope: Clinical efficacy and safety reports, synopses, datasets
Examples: 5.2 study reports, 5.3 literature, ISS/ISE summaries in 2.7
| Element | FDA (US) | EMA (EU) |
|---|---|---|
| Application form | Form FDA 356h and regional forms | EU application form per procedure type |
| Labeling | US Prescribing Information (SPL) | SmPC, labeling, mock-ups, specimens |
| Patents / exclusivity | Orange Book certifications, exclusivity claims | IP and data exclusivity statements per EU law |
| Risk management | REMS (when required) | RMP (Risk Management Plan) |